You have 9 free searches left this month | for more free features.

Anthracycline

Showing 26 - 50 of 903

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pathogenesis of Anthracycline Cardiotoxicity

Not yet recruiting
  • Childhood Cancer
  • Cardiac MRI
  • +2 more
  • Hartford, Connecticut
    Olga Salazar
Jan 11, 2022

Cardiomyopathies, Chemo Effect, Diastolic Dysfunction Trial in Tehran (Bisoprolol, Placebo)

Completed
  • Cardiomyopathies
  • +3 more
  • Tehran, Iran, Islamic Republic of
    Rasool Akram hospital
Dec 30, 2021

Leukemia, Cardiac Toxicity Trial in Pessac (Echographic analysis of myocardial deformation in 2D strain)

Completed
  • Leukemia
  • Cardiac Toxicity
  • Echographic analysis of myocardial deformation in 2D strain
  • Pessac, France
    Service de Cardiologie et Maladies Vasculaires, Hopital du Haut
Feb 8, 2022

Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer

Active, not recruiting
  • Cancer
  • Cardiotoxicity
  • Exercise program
  • Hartford, Connecticut
  • +1 more
Jan 11, 2022

Defining Late Onset Occult Asymptomatic Cardiotoxicity in

Active, not recruiting
  • Cardiovascular Disease
  • Cardiac MRI
  • Hartford, Connecticut
    Connecticut Children's Medical Center
Jan 11, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +4 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Jun 26, 2023

Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
Jan 20, 2023

Cancer, Heart Failure, Cardiotoxicity Trial in Toronto (Atorvastatin, Placebo oral tablet)

Active, not recruiting
  • Cancer
  • +2 more
  • Toronto, Ontario, Canada
    Toronto General Hospital
Feb 4, 2022

Cancer Trial in Milan (Enalapril)

Active, not recruiting
  • Cancer
  • Milan, Italy
    European Institute of Oncology
Aug 12, 2021

Advanced Solid Tumors Amenable to Anthracycline Therapy, Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer

Completed
  • Advanced Solid Tumors Amenable to Anthracycline Therapy
  • Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy
  • Münster, Germany
  • +1 more
Apr 1, 2022

Breast Cancer Trial (non invasive auricular vagal stimulation, usual medical treatment, sham stimulation)

Not yet recruiting
  • Breast Cancer
  • non invasive auricular vagal stimulation
  • +2 more
  • (no location specified)
May 17, 2022

Checkpoint Inhibitors in Triple Negative Breast

Recruiting
  • Triple Negative Breast Cancer
  • Whole Genome Sequencing
  • +7 more
  • Barcelona, Spain
    Vall d'Hebron Institute of Oncology
Jun 20, 2023

Breast Tumors Trial in Shanghai (Epirubicin, Docetaxel, cyclophosphamide)

Completed
  • Breast Neoplasms
  • Shanghai, Shanghai, China
    Ruijin Hospital
Oct 26, 2022

Anthracycline Related Cardiotoxicity in Breast Cancer Trial in Lubbock (sulforaphane, Placebo Oral Tablet)

Recruiting
  • Anthracycline Related Cardiotoxicity in Breast Cancer
  • Lubbock, Texas
    Texas Tech University Health Sciences Center
Jul 18, 2022

Breast Cancer, Cancer of the Breast Trial in Saint Louis (VENTANA MIB-1 Ki67 assay, Oncotype DX® Recurrence Score, PAM50-based

Not yet recruiting
  • Breast Cancer
  • Cancer of the Breast
  • VENTANA MIB-1 Ki67 assay
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 18, 2023

Physical Exercise Intervention in Breast Cancer Patients at Risk

Recruiting
  • Breast Cancer
    • Aberdeen, Aberdeenshire, United Kingdom
      Cardiovascular Research Facility
    Sep 29, 2021

    During Non-anthracycline Trastuzumab-based Therapy in Breast

    Recruiting
    • Breast Cancer
    • Left Ventricular Ejection Fraction
    • Hartford, Connecticut
    • +7 more
    Mar 7, 2022

    Breast Cancer, Triple Negative Breast Cancer Trial in Los Angeles (Durvalumab, Radiation Therapy, Carboplatin)

    Withdrawn
    • Breast Cancer
    • Triple Negative Breast Cancer
    • Los Angeles, California
      Cedars Sinai Medical Center
    Aug 19, 2021

    Luminal B/HER2-negative Breast Cancer Trial in Hangzhou (Dalpiciclib combined with aromatase inhibitors,

    Recruiting
    • Luminal B/HER2-negative Breast Cancer
    • Dalpiciclib combined with aromatase inhibitors
    • anthracycline-cyclophosphamide followed by taxane
    • Hangzhou, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Nov 30, 2022

    Breast Cancer, Non Hodgkin Lymphoma Trial in Middlesbrough (Enalapril)

    Recruiting
    • Breast Cancer
    • Non Hodgkin Lymphoma
    • Middlesbrough, Teesside, United Kingdom
      South Tees Hospitals NHS FT
    Oct 20, 2022

    Cardiomyopathy, Heart Failure Trial in Houston (Laboratory Biomarker Analysis, Standard of Care, Mesenchymal Stem Cell

    Completed
    • Cardiomyopathy
    • Heart Failure
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 11, 2022

    Breast Cancer Trial in Amsterdam (anthracycline-based, docetaxel and capecitabine, tamoxifen)

    Completed
    • Breast Cancer
    • Amsterdam, Netherlands
      Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
    Nov 16, 2022

    Chemo-induced Nausea and Vomiting Trial in Henan, Zhengzhou (Fosaprepitant , Tropisetron and Olanzapine, Fosaprepitant ,

    Recruiting
    • Chemotherapy-induced Nausea and Vomiting
    • Fosaprepitant , Tropisetron and Olanzapine
    • Fosaprepitant , Tropisetron, Dexamethasoneand Olanzapine
    • Henan, Henan, China
    • +1 more
    Apr 11, 2022

    Metastatic Breast Cancer Trial in Worldwide (Ixabepilone Injection)

    Recruiting
    • Metastatic Breast Cancer
    • Ixabepilone Injection
    • Aalst, Belgium
    • +11 more
    Nov 28, 2022